These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Assay of plasma isosorbide dinitrate and its metabolites after oral administration of immediate and delayed-action forms]. Audry E, Dallet P, Dubost JP, Langlois MH, Ernouf D, Narcisse G. Ann Pharm Fr; 1989; 47(4):235-41. PubMed ID: 2637644 [Abstract] [Full Text] [Related]
24. [Long-term percutaneous therapy of angina pectoris with isosorbide dinitrate with reference to isosorbide dinitrate blood levels]. Kriehuber E, Prey T, Orthofer R. Wien Med Wochenschr; 1982 Jun 30; 132(12):295-302. PubMed ID: 7123974 [Abstract] [Full Text] [Related]
25. [Pharmacokinetics of low-dose isosorbide dinitrate and metabolites after buccal or oral administration]. Keller-Stanislawski B, Marschner JP, Rietbrock N. Arzneimittelforschung; 1992 Jan 30; 42(1):17-20. PubMed ID: 1586374 [Abstract] [Full Text] [Related]
26. [Influence of isosorbiddinitrate on hemodynamics at rest and during exercise (author's transl)]. Spiel R, Dittel M, Kiss E, Nobis H, Prachar H, Spiel C, Enenkel W. Z Kardiol; 1980 Jun 30; 69(6):444-51. PubMed ID: 7445646 [Abstract] [Full Text] [Related]
27. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance? Kośmicki M, Sadowski Z, Szwed H, Kowalik I. Med Sci Monit; 2000 Jun 30; 6(4):763-8. PubMed ID: 11208406 [Abstract] [Full Text] [Related]
28. [Hemodynamic effects of a new long-acting isosorbide dinitrate]. Curti-Karbowski E, Galeazzi RL, Straehl P, Baur HR. Schweiz Med Wochenschr; 1985 Nov 23; 115(47):1698-701. PubMed ID: 4081701 [Abstract] [Full Text] [Related]
34. Tolerance to isosorbide dinitrate: rate of development and reversal. Parker JO, Fung HL, Ruggirello D, Stone JA. Circulation; 1983 Nov 23; 68(5):1074-80. PubMed ID: 6616789 [Abstract] [Full Text] [Related]
35. A comparison of the haemodynamic effect of isosorbide-5-mononitrate and isosorbide dinitrate administered in intravenous injection to patients with acute myocardial infarction. Daskalov TR. Cor Vasa; 1989 Nov 23; 31(5):376-86. PubMed ID: 2612170 [Abstract] [Full Text] [Related]
36. Randomized study to evaluate the relation between oral isosorbide dinitrate dosing interval and the development of early tolerance to its effect on left ventricular filling pressure in patients with chronic heart failure. Elkayam U, Roth A, Mehra A, Ostrzega E, Shotan A, Kulick D, Jamison M, Johnston JV, Rahimtoola SH. Circulation; 1991 Nov 23; 84(5):2040-8. PubMed ID: 1934379 [Abstract] [Full Text] [Related]
37. [The effects of isosorbide dinitrate spray on the coronary artery and its modification by the preceding chronic oral therapy with long acting isosorbide dinitrate]. Maeda T, Saikawa T, Niwa H, Simoyama N, Kohmatsu K, Yonemochi H, Inoue T, Maruyama T, Takaki R, Fukuoka Y. Kokyu To Junkan; 1992 Jan 23; 40(1):83-7. PubMed ID: 1557564 [Abstract] [Full Text] [Related]
39. [Effects of intravenous infusion of isosorbide dinitrate on hemodynamics during anesthesia and surgery]. Murakawa T, Ishihara H, Matsuki A, Takazawa T, Kimura K, Maeda A, Wakayama S, Nagao H. Masui; 1993 Jan 23; 42(1):71-6. PubMed ID: 8433497 [Abstract] [Full Text] [Related]
40. Effects of disease, route of administration, cigarette smoking, food intake on the pharmacokinetics and circulatory effects of isosorbide dinitrate. Fung HL, Ruggirello D, Stone JA, Parker JO. Z Kardiol; 1983 Jan 23; 72 Suppl 3():5-10. PubMed ID: 6666234 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]